Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients—real-world data - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients—real-world data

21

Citations

14

References

2018

Year

M Polkowska, P Ekk-Cierniakowski, Edyta Czepielewska, Małgorzata Kozłowska−Wojciechowska

European Journal of Clinical Pharmacology

Melanoma Patients—real-world DataMedicineMelanomaImmunologyImmune Checkpoint InhibitorDermatologyCancer TreatmentImmunotherapyOncologyMolecular OncologyAnti-ctla4 AntibodyBraf Inhibitors

References

	Year	Citations

Page 1